Evidence map›Paper›PMID 37484197›Full record

ArticleBrain, behavior, & immunity - health2023

Parkinson's disease relevant pathological features are manifested in male Pink1/Parkin deficient rats.

Benjamin G Lamberty, L Daniel Estrella, Jane E Mattingly, Katy Emanuel, Andrew Trease, Steven Totusek, Lexi Sheldon, Joseph W George, Mohannad A Almikhlafi, Trey Farmer and 1 more

Open access · goldAbstract read
In one paragraph

Article in Brain, behavior, & immunity - health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. A novel rat model of body first subtype of Parkinson's disease.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Targeting mitophagy in neurodegenerative diseases.Nature reviews. Drug discovery · 2025
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Benjamin G LambertyUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
L Daniel EstrellaUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Jane E MattinglyUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Katy EmanuelUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Andrew TreaseUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Steven TotusekUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Lexi SheldonUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Joseph W GeorgeUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Mohannad A AlmikhlafiUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Trey FarmerUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
Kelly L StauchUniversity of Nebraska Medical Center, College of Medicine, Department of Neurological Sciences, Omaha, NE, USA.
University of Nebraska Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal disease models are important for neuroscience experimentation and in the study of neurodegenerative disorders. The major neurodegenerative disorder leading to motor impairments is Parkinson's disease (PD). The identification of hereditary forms of PD uncovered gene mutations and variants, such as loss-of-function mutations in PTEN-induced putative kinase 1 (Pink1) and the E3 ubiquitin ligase Parkin, two proteins involved in mitochondrial quality control, that could be harnessed to create animal models. However, to date, such models have not reproducibly recapitulated major aspects of the disease. Here, we describe the generation and phenotypic characterization of a combined Pink1/Parkin double knockout (dKO) rat, which reproducibly exhibits PD-relevant abnormalities, particularly in male animals. Motor dysfunction in Pink1/Parkin dKO rats was characterized by gait abnormalities and decreased rearing frequency, the latter of which was responsive to levodopa treatment. Pink1/Parkin dKO rats exhibited elevated plasma levels of neurofilament light chain and significant loss of tyrosine hydroxylase expression in the substantia nigra pars compacta (SNpc). Glial cell activation was also observed in the SNpc. Pink1/Parkin dKO rats showed elevated plasma and reduced cerebrospinal levels of alpha-synuclein as well as the presence of alpha-synuclein aggregates in the striatum. Further, the profile of circulating lymphocytes was altered, as elevated CD3

Indexed as

Alpha-synucleinMotor symptomsNeurodegenerationParkin/Pink1T cellsTremor

Identifiers

PMID37484197
PMCPMC10362548
OpenAlexW4381248605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.